辐射诱导的细胞可塑性为福斯科林介导的差异化使质母细胞瘤成为首要因素
Ling He1,2, Daria Azizad3, Kruttika Bhat1
1Department of Radiation Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095.
概括
这项研究表明,将福斯科林与放射治疗结合起来,可以将致命的脑癌细胞 (质母细胞瘤) 重新编程成神经元类细胞,显著改善小鼠模型中的生存率.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 细胞分化 细胞分化
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑癌.
- 目前的手术,化疗和向疗法等治疗方法提供了有限的生存益处.
- 质瘤干细胞 (GSCs) 与瘤复发和治疗耐药性有关.
研究的目的:
- 为了研究组合福斯科林的潜力,一个腺酶激活剂,与辐射改变质瘤细胞命运.
- 在GBM模型中评估这种联合治疗对细胞标记物,增殖和生存的影响.
主要方法:
- 利用批量和单细胞RNA测序 (scRNA-seq) 来分析基因表达和细胞群变化.
- 对神经元标记物表达,细胞循环和增殖的评估影响.
- 使用极限限稀释试验研究了对质瘤干细胞 (GSC) 的影响.
- 在GBM的同源性和患者衍生的异种移植 (PDOX) 鼠标模型中评估的中位生存时间.
主要成果:
- 福斯科林和放射治疗的结合诱导了神经元标记物在质瘤细胞中的表达.
- 观察到细胞增殖的减少和基因表达的改变.
- scRNA-seq表明了向微质和神经元类表型的转变.
- 在体内研究表明,GSCs的减少和延长中位生存时间.
结论:
- 使用福斯科林和辐射重新编程质瘤细胞以实现神经元命运是一种可行的治疗策略.
- 这种方法显示出克服治疗耐药性和改善质母细胞瘤的结果的希望.
- 需要对这种差异化治疗组合进行进一步的临床研究.
更多相关视频
12:25Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
Published on: January 7, 2014
15.1K
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
8.3K
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
